Prospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2014; 20(21): 6658-6665
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6658
Figure 1
Figure 1 Overall survival of 194 patients who underwent resection (n = 133) or nonresectional surgeries (n = 61) for middle and distal bile duct cancers.
Figure 2
Figure 2 Overall survival of the 133 patients who underwent resection according to the status of their resection margins.
Figure 3
Figure 3 Overall (A) and disease free (B) survival of the patients according to R0-pancreatoduodenectomy and R0-bile duct resection.